Acadia Pharmaceuticals | ACAD - 現金と同等





現金と同等 変化する 日付
Acadia Pharmaceuticals USD 976.45M 19.97M 2026-09
ALKERMES USD 631.31M 119.78M 2026-09
Alnylam Pharmaceuticals USD 1.75B 46.02M 2026-09
Biogen USD 1.3B 18.9M 2026-09
BioMarin Pharmaceutical USD 736.01M 138M 2026-09
Bristol-Myers Squibb USD 9.57B 852M 2026-09
Cara Therapeutics USD 22.28M 2.42M 2026-09
Corcept Therapeutics USD 98.72M 12.32M 2026-09
Cytokinetics USD 203.43M 51.84M 2026-09
Eisai JPY 245.42B 56.22B 2026-03
Eli Lilly USD 4.89B 4.07B 2026-09
Incyte USD 3.85B 127.8M 2026-09
J&J USD 16.91B 3.51B 2026-09
Moderna USD 1.2B 528M 2026-09
Neurocrine Biosciences USD 641.5M 309.1M 2026-09
Pfizer USD 1.82B 848M 2026-09
Prothena USD 271.37M 16.82M 2026-09
PTC Therapeutics USD 508.89M 540.99M 2026-09
Sarepta Therapeutics USD 472.76M 98.39M 2026-09
Ultragenyx Pharmaceutical USD 150M 25M 2026-09
Vanda Pharmaceuticals USD 84.85M 14.83M 2025-12
Vertex Pharmaceuticals USD 6.3B 1.55B 2026-09